David A. Siegel Repligen Corp Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Repligen Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 24,200 shares of RGEN stock, worth $3.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,200Holding current value
$3.53 Million% of portfolio
0.01%Shares
16 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$739 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$672 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$253 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$207 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.09B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....